Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers.
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML.
Oncogene
Lindblad, O O; Cordero, E E; Puissant, A A; Macaulay, L L; Ramos, A A; Kabir, N N NN; Sun, J J; Vallon-Christersson, J J; Haraldsson, K K; Hemann, M T MT; Borg, Å Å; Levander, F F; Stegmaier, K K; Pietras, K K; Rönnstrand, L L; Kazi, J U JU